Published in AIDS Weekly, October 18th, 1999
Ziagen currently is approved for use in adults and children in combination with other antiretroviral agents to treat HIV-1 infection. This indication is based on analyses of surrogate markers in controlled studies of up to 24 weeks in duration. Until now, no results from controlled trials...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.